Roberta Camisa

2.2k total citations · 1 hit paper
44 papers, 1.5k citations indexed

About

Roberta Camisa is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Roberta Camisa has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Roberta Camisa's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Roberta Camisa is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers) and Lung Cancer Treatments and Mutations (10 papers). Roberta Camisa collaborates with scholars based in Italy, Malaysia and Canada. Roberta Camisa's co-authors include Nadia Naldi, Andrea Ardizzoni, Marzia Capelletti, Antonino Musolino, Debora Pezzuolo, Beatrice Bortesi, Tauro Maria Neri, Giancarlo Bisagni, Gabriele Missale and Alessandro Zerbini and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Roberta Camisa

43 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer

2008 745 citations Antonino Musolino, Nadia Naldi et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberta Camisa Italy	17	872	535	448	364	290	44	1.5k
Antoine Yver United States	17	1.3k 1.5×	428 0.8×	344 0.8×	140 0.4×	114 0.4×	36	1.8k
Gisela Schwab United States	13	644 0.7×	334 0.6×	361 0.8×	166 0.5×	126 0.4×	23	1.3k
Peter Vuylsteke Belgium	19	1.1k 1.3×	167 0.3×	439 1.0×	143 0.4×	383 1.3×	101	1.7k
G. N. Hortobagyi United States	21	1.4k 1.6×	411 0.8×	447 1.0×	80 0.2×	617 2.1×	109	2.1k
Aurélie Bertaut France	24	838 1.0×	167 0.3×	357 0.8×	303 0.8×	291 1.0×	105	1.8k
Ngan‐Ming Tsang Taiwan	20	553 0.6×	159 0.3×	378 0.8×	159 0.4×	258 0.9×	57	1.3k
Jayaprakash Madhavan India	19	863 1.0×	243 0.5×	456 1.0×	88 0.2×	197 0.7×	40	1.9k
Véronique D’Hondt France	21	781 0.9×	110 0.2×	298 0.7×	120 0.3×	241 0.8×	83	1.3k
Ulrika Harmenberg Sweden	23	736 0.8×	281 0.5×	693 1.5×	262 0.7×	375 1.3×	57	1.7k
Noh-Hyun Park South Korea	29	441 0.5×	432 0.8×	398 0.9×	67 0.2×	238 0.8×	77	2.1k

Countries citing papers authored by Roberta Camisa

Since Specialization

Citations

This map shows the geographic impact of Roberta Camisa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Camisa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Camisa more than expected).

Fields of papers citing papers by Roberta Camisa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Camisa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Camisa. The network helps show where Roberta Camisa may publish in the future.

Co-authorship network of co-authors of Roberta Camisa

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Camisa. A scholar is included among the top collaborators of Roberta Camisa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Camisa. Roberta Camisa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bersanelli, Melissa, Letizia Gnetti, Francesco Paolo Pilato, et al.. (2023). Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity. SHILAP Revista de lepidopterología. 4(4). 743–756.

Bersanelli, Melissa, Fabiana Perrone, Roberta Camisa, et al.. (2020). Clinical Impact of COVID-19 in a Single-Center Cohort of a Prospective Study in Cancer Patients Receiving Immunotherapy. Immunotherapy. 12(15). 1139–1148. 7 indexed citations

Buti, Sebastiano, Paola Bordi, Marcello Tiseo, et al.. (2015). Predictive role of erythrocyte macrocytosis during treatment with pemetrexed in advanced non-small cell lung cancer patients. Lung Cancer. 88(3). 319–324. 6 indexed citations

Passalacqua, Rodolfo, Caterina Caminiti, Sebastiano Buti, et al.. (2014). Adjuvant Low-Dose Interleukin-2 (IL-2) Plus Interferon-α (IFN-α) in Operable Renal Cell Carcinoma (RCC). Journal of Immunotherapy. 37(9). 440–447. 59 indexed citations

Tiseo, Marcello, Melissa Bersanelli, Marco Bartolotti, et al.. (2013). Asymptomatic pulmonary embolism in lung cancer: prevalence and analysis of clinical and radiological characteristics in 141 outpatients.. PubMed. 98(5). 594–600. 12 indexed citations

Tiseo, Marcello, Giulio Rossi, Marzia Capelletti, et al.. (2009). Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): Study of a comprehensive panel of molecular markers. Lung Cancer. 67(3). 355–360. 61 indexed citations

Passalacqua, Rodolfo, Carlo Buzio, Sebastiano Buti, et al.. (2009). Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer. Cancer Immunology Immunotherapy. 59(4). 553–561. 18 indexed citations

Bonaguri, Chiara, Alessandra Melegari, Pierpaolo Dall’Aglio, et al.. (2009). An Italian Multicenter Study for Application of a Diagnostic Algorithm in Autoantibody Testing. Annals of the New York Academy of Sciences. 1173(1). 124–129. 11 indexed citations

Musolino, Antonino, Nadia Naldi, Beatrice Bortesi, et al.. (2008). Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/ neu –Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 26(11). 1789–1796. 745 indexed citations breakdown →

10.

Tiseo, Marcello, Marzia Capelletti, Giuseppe De Palma, et al.. (2008). Epidermal Growth Factor Receptor Intron-1 Polymorphism Predicts Gefitinib Outcome in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 3(10). 1104–1111. 23 indexed citations

11.

Musolino, Antonino, Maria Angela Bella, Beatrice Bortesi, et al.. (2007). BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. The Breast. 16(3). 280–292. 101 indexed citations

12.

Scartozzi, Mario, Vittorio Franciosi, Nicoletta Campanini, et al.. (2006). Mismatch repair system (MMR) status correlates with response and survival in non-small cell lung cancer (NSCLC) patients. Lung Cancer. 53(1). 103–109. 27 indexed citations

13.

Bozzetti, Cecilia, Antonino Musolino, Roberta Camisa, et al.. (2006). Evaluation of HER-2/Neu Amplification and Other Biological Markers as Predictors of Response to Neoadjuvant Anthracycline-Based Chemotherapy in Primary Breast Cancer. American Journal of Clinical Oncology. 29(2). 171–177. 32 indexed citations

14.

Musolino, Antonino, Maria Michiara, Maria Angela Bella, et al.. (2005). Molecular Profile and Clinical Variables in Brca1-Positive Breast Cancers. A Population-Based Study. Tumori Journal. 91(6). 505–512. 14 indexed citations

15.

Musolino, Antonino, Maria Michiara, Vittorio Franciosi, et al.. (2005). Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO‐P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non‐Hodgkin lymphoma. Cancer. 103(10). 2109–2117. 8 indexed citations

16.

Franciosi, Vittorio, et al.. (2003). Gemcitabine and oxaliplatin: a safe and active regimen in poor prognosis advanced non-small cell lung cancer patients. Lung Cancer. 41(1). 101–106. 24 indexed citations

17.

Cascinu, Stefano, Paolo Giordani, Giampietro Gasparini, et al.. (2003). Pain and its treatment in hospitalized patients with metastatic cancer. Supportive Care in Cancer. 11(9). 587–592. 35 indexed citations

18.

Cocconi, Giorgio, C. Boni, Giancarlo Bisagni, et al.. (2002). Randomized trial comparing cyclophosphamide, methotrexate, and 5–fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma. Cancer. 95(2). 228–235. 6 indexed citations

19.

Nizzoli, Rita, Nadia Naldi, Annamaria Guazzi, et al.. (2000). Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas. Cancer. 90(1). 61–66. 43 indexed citations

20.

Bozzetti, Cecilia, Rita Nizzoli, Nadia Naldi, et al.. (1996). Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer. Diagnostic Cytopathology. 15(2). 116–120. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact